Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

19.10
Delayed Data
As of Jun 22
 +0.15 / +0.79%
Today’s Change
11.90
Today|||52-Week Range
20.40
+25.66%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Sale1/02/2018170,225$15.30$2.6M+22.44%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Buy1/02/2018250,000$5.76$1.4M+22.44%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Sale3/01/201860,966$18.72$1.1M+2.14%
Polymeropoulos Mihael Hristos
President & Chief Executive Officer
Sale1/02/201821,535$15.30$329.5K+22.44%
Kelly James Patrick /vanda/
Chief Financial Officer & Executive Vice President
Sale3/01/20188,532$18.72$159.7K+2.14%
Birznieks Gunther
Senior Vice President-Business Development
Sale3/01/20188,525$18.72$159.6K+2.14%
Gulino Richard L
General Counsel & Senior Vice President
Sale1/02/201810,367$15.20$157.6K+22.44%
Kelly James Patrick /vanda/
Chief Financial Officer & Executive Vice President
Sale1/02/20189,155$15.35$140.5K+22.44%
Birznieks Gunther
Senior Vice President-Business Development
Sale1/02/20188,568$15.26$130.7K+22.44%
Watkins H Thomas
Director
Buy5/03/201815,000$4.98$74.7K+22.04%
Page of 4